Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 19 July, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo

Fundamental Analysis of Hemant Surgical Industries Ltd

About the Company - Hemant Surgical Industries Ltd

Medical Equipment & Accessories
INDUSTRYADDRESSCONTACT
502, 5th Floor, Ecstasy Business Park Co-Op Socteiy Limited, Mumbai Maharashtra 400080Mr.Hanskumar%20Shamji%20Shah
Chairman%20&%20Managing%20Director
Management
NamePosition Held
Mr. Hemant Praful ShahWhole Time Director
Mr. Kaushik Hanskumar ShahWholeTime Director & CFO
Mrs. Nehal Babu KareliaNon Executive Director
Mrs. Pooja Kirti KothariIndependent Director
Mr. Sourabh AjmeraIndependent Director

Basic Stock Data of Hemant Surgical Industries Ltd

Last Updated: July 18, 2024, 11:04 pm

Market Cap 206 Cr.
Current Price 197
High / Low260/115
Stock P/E21.0
Book Value 52.6
Dividend Yield0.00 %
ROCE44.8 %
ROE41.5 %
Face Value 10.0
PEG Ratio0.45

Data Source: screener.in

Hemant Surgical Industries Ltd Quarterly Results

MonthSep 2022Sep 2023
Sales5148
Expenses4744
Operating Profit43
OPM %8%7%
Other Income13
Interest11
Depreciation01
Profit before tax45
Tax %36%17%
Net Profit24
EPS in Rs124.733.75

Last Updated: July 11, 2024, 8:11 am

Hemant Surgical Industries Ltd Quarterly Chart

Hemant Surgical Industries Ltd Profit & Loss

Last Updated: July 10, 2024, 5:24 pm

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Sales51565660101109
Expenses485353579598
Operating Profit2333611
OPM %5%5%5%5%6%10%
Other Income000122
Interest112222
Depreciation010111
Profit before tax1111610
Tax %10%8%41%9%25%24%
Net Profit110158
EPS in Rs50.7661.0227.0073.43248.92413.07
Dividend Payout %0%0%0%0%0%0%

Hemant Surgical Industries Ltd Profit & Loss Yearly Chart

Hemant Surgical Industries Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:14%
3 Years:21%
TTM:-3%
Compounded Profit Growth
10 Years:%
5 Years:54%
3 Years:93%
TTM:28%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:-13%
Return on Equity
10 Years:%
5 Years:34%
3 Years:41%
Last Year:42%

Last Updated: July 16, 2024, 11:13 pm

Hemant Surgical Industries Ltd Balance Sheet

Last Updated: July 10, 2024, 5:24 pm

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital22222810
Reserves5658111638
Borrowings91114141077
Other Liabilities12142315323434
Total Liabilities28334440546590
Fixed Assets781011121317
CWIP0000000
Investments0010100
Other Assets21253329425173
Total Assets28334440546590

Hemant Surgical Industries Ltd Reserves and Borrowings Chart

Hemant Surgical Industries Ltd Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity 002-4129-8
Cash from Investing Activity 00-2-2-0-2-9
Cash from Financing Activity 0025-8-421
Net Cash Flow002-2435

Hemant Surgical Industries Ltd Financial Efficiency Indicators

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days353635265658
Inventory Days64731251135767
Days Payable102971438992110
Cash Conversion Cycle-31217512115
Working Capital Days12231466215
ROCE %15%12%14%32%45%

Hemant Surgical Industries Ltd Financial Efficiency Indicators Chart

Hemant Surgical Industries Ltd Share Holding Pattern

MonthSep 2023Mar 2024
Promoters73.56%73.56%
FIIs0.03%0.00%
DIIs4.26%1.97%
Public22.14%24.47%
No. of Shareholders7221,229

Hemant Surgical Industries Ltd Shareholding Pattern Chart

No. of Hemant Surgical Industries Ltd Shareholders

This stock is not held by any mutual fund

Hemant Surgical Industries Ltd ROCE Trend

Hemant Surgical Industries Ltd EPS Trend

Hemant Surgical Industries Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.00100.00
Basic EPS (Rs.)9.8510.288.962.2232.90
Diluted EPS (Rs.)9.8510.288.962.2232.90
Cash EPS (Rs.)10.3711.0726.818.9073.82
Book Value[Excl.RevalReserv]/Share (Rs.)52.5530.7365.7442.67400.80
Book Value[Incl.RevalReserv]/Share (Rs.)52.5530.7365.7442.67400.80
Revenue From Operations / Share (Rs.)101.16142.12517.85298.822805.11
PBDIT / Share (Rs.)14.1616.6942.5019.81150.54
PBIT / Share (Rs.)13.1715.5938.7616.64119.62
PBT / Share (Rs.)12.2413.1030.567.6047.90
Net Profit / Share (Rs.)9.399.9623.075.7342.90
PBDIT Margin (%)13.9911.748.206.625.36
PBIT Margin (%)13.0210.967.485.564.26
PBT Margin (%)12.109.215.902.541.70
Net Profit Margin (%)9.277.004.451.911.52
Return on Networth / Equity (%)17.8632.4235.0913.4210.70
Return on Capital Employeed (%)23.3744.3744.5116.4714.29
Return On Assets (%)10.1411.788.482.662.07
Long Term Debt / Equity (X)0.060.120.311.211.09
Total Debt / Equity (X)0.120.300.741.691.76
Asset Turnover Ratio (%)1.311.832.131.421.50
Current Ratio (X)1.831.231.021.131.05
Quick Ratio (X)1.280.840.670.470.45
Inventory Turnover Ratio (X)4.475.935.893.323.88
Interest Coverage Ratio (X)15.216.705.192.192.10
Interest Coverage Ratio (Post Tax) (X)11.095.003.811.631.60
Enterprise Value (Cr.)132.590.000.000.000.00
EV / Net Operating Revenue (X)1.260.000.000.000.00
EV / EBITDA (X)8.970.000.000.000.00
MarketCap / Net Operating Revenue (X)1.320.000.000.000.00
Price / BV (X)2.530.000.000.000.00
Price / Net Operating Revenue (X)1.320.000.000.000.00
EarningsYield0.070.000.000.000.00

Hemant Surgical Industries Ltd Profitability Ratios (%)

Hemant Surgical Industries Ltd Liquidity Ratios

Hemant Surgical Industries Ltd Liquidity Ratios (%)

Hemant Surgical Industries Ltd Interest Coverage Ratios (%)

Hemant Surgical Industries Ltd Valuation Ratios

Fair Value

Fair Value: 467.58

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 137.35% compared to the current price 197

Intrinsic Value: 685.43

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 247.93% compared to the current price 197

Last 5 Year EPS CAGR: 46.59%

*Investments are subject to market risks

Strength and Weakness of Hemant Surgical Industries Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 16.86%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 18.86, which is a positive sign.
  3. The company has higher reserves (13.57 cr) compared to borrowings (10.29 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (72.17 cr) and profit (3.33 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 16.14, which may not be favorable.

FAQ

What is the latest fair value of Hemant Surgical Industries Ltd?

The latest fair value of Hemant Surgical Industries Ltd is ₹467.58.

What is the Market Cap of Hemant Surgical Industries Ltd?

The Market Cap of Hemant Surgical Industries Ltd is 206 Cr..

What is the current Stock Price of Hemant Surgical Industries Ltd as on 19 July 2024?

The current stock price of Hemant Surgical Industries Ltd as on 19 July 2024 is 197.

What is the High / Low of Hemant Surgical Industries Ltd stocks in FY 2024?

In FY 2024, the High / Low of Hemant Surgical Industries Ltd stocks is 260/115.

What is the Stock P/E of Hemant Surgical Industries Ltd?

The Stock P/E of Hemant Surgical Industries Ltd is 21.0.

What is the Book Value of Hemant Surgical Industries Ltd?

The Book Value of Hemant Surgical Industries Ltd is 52.6.

What is the Dividend Yield of Hemant Surgical Industries Ltd?

The Dividend Yield of Hemant Surgical Industries Ltd is 0.00 %.

What is the ROCE of Hemant Surgical Industries Ltd?

The ROCE of Hemant Surgical Industries Ltd is 44.8 %.

What is the ROE of Hemant Surgical Industries Ltd?

The ROE of Hemant Surgical Industries Ltd is 41.5 %.

What is the Face Value of Hemant Surgical Industries Ltd?

The Face Value of Hemant Surgical Industries Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Hemant Surgical Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE